Publication | Closed Access

Comparison of the safety and immunogenicity of hepatitis B virus surface antigen co-administered with an immunostimulatory phosphorothioate oligonucleotide and a licensed hepatitis B vaccine in healthy young adults

VaccinationVaccine SafetyVaccine DevelopmentViral HepatitisImmunologyHepatitis BHepatitisVirologyHealthy Young AdultsPolyvalent VaccineMedicineImmunostimulatory Phosphorothioate Oligonucleotide